The Indian Patent Office has refused patent to Wyeth, a group company of Pfizer Inc., in response to representation for Pre-grant opposition filed by Fresenius Kabi (formerly Dabur Pharma Ltd.). The pre-grant opposition is against a divisional patent application filed by Wyeth (1155/KOLNP/2007) claiming stable parenteral formulations having a rapamycin hydroxyester (CCI-779). The grounds for...

In response to clubbing India with other countries in the “Priority watch list” of special 301 report released by USTR, the Commerce and Industry Minister, Nirmala Sitharaman stated that India will keep its national interest in mind while framing the new IPR policy and will not respond to outside pressure. She also stated that the...

GVK Biosciences, a contract research organization that conducts clinical trials for many reputed generic manufacturers in India and foreign countries is facing rough weather following the harsh recommendations made by the European Medicines Agency (EMA). The trouble started for GVK last May when ANSM, the French drug regulatory agency alleged data manipulation of “check-out ECGs”...

Stempeutics Research, a stem cell research company having facilities in India as well as in Malaysia has obtained a Chinese patent (Chinese Application No. CN 201080053627) for its lead product-Stempeucel. The company has obtained patent rights in US as well (US 8956862) for the same technology. Stempeutics Research is the first company in the world...